Prostate Cancer
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.
November 3, 2022
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.
November 2, 2022
Transurethral Vapor Ablation in Patients with Intermediate Risk Localized Prostate Cancer.
November 2, 2022
Molecular Mechanisms of Castrate-Resistant Prostate Cancer.
November 1, 2022
Testosterone Therapy and Prostate Cancer: Incorporating Low-Level Evidence into Practical Recommendations.
November 1, 2022
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.
November 1, 2022
Patterns of metastases progression- The linear parallel ratio.
November 1, 2022
Movember Launches First of Its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer
October 31, 2022